|
C3ORF34 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.13100000037814E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.431110E-04 |
| Normal-vs-Stage2 |
4.173600E-02 |
| Normal-vs-Stage3 |
9.217200E-03 |
| Normal-vs-Stage4 |
9.077200E-03 |
| Stage1-vs-Stage2 |
9.763400E-01 |
| Stage1-vs-Stage3 |
4.285000E-01 |
| Stage1-vs-Stage4 |
9.961400E-01 |
| Stage2-vs-Stage3 |
6.003600E-01 |
| Stage2-vs-Stage4 |
9.860000E-01 |
| Stage3-vs-Stage4 |
5.493400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.74369999994539E-06 |
| Normal-vs-AfricanAmerican |
3.372900E-04 |
| Normal-vs-Asian |
1.596580E-01 |
| Caucasian-vs-AfricanAmerican |
7.190800E-01 |
| Caucasian-vs-Asian |
7.563600E-01 |
| AfricanAmerican-vs-Asian |
6.124200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.16530000002524E-06 |
| Normal-vs-Female |
1.52677999999407E-05 |
| Male-vs-Female |
1.708040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.265900E-02 |
| Normal-vs-Extreme_Weight |
5.122200E-03 |
| Normal-vs-Obese |
1.77893999999679E-05 |
| Normal-vs-Extreme_Obese |
8.292400E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.309800E-01 |
| Normal_Weight-vs-Obese |
3.012500E-02 |
| Normal_Weight-vs-Extreme_Obese |
1.308030E-01 |
| Extreme_Weight-vs-Obese |
2.659000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.413800E-01 |
| Obese-vs-Extreme_Obese |
7.206000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.458700E-03 |
| Normal-vs-Age(41-60Yrs) |
1.38019999873507E-08 |
| Normal-vs-Age(61-80Yrs) |
1.003300E-03 |
| Normal-vs-Age(81-100Yrs) |
3.502600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.569200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.082600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.072380E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.864700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.513600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.144000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.05769995381888E-09 |
| Normal-VS-Type2 PRCC |
1.214430E-01 |
| Normal-VS-KIRP CIMP |
2.162100E-04 |
| Normal-VS-Unclassified PRCC |
2.904400E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.554600E-04 |
| Type1 PRCC-VS-KIRP CIMP |
8.487400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.581800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.008780E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.519600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.629600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.794300E-02 |
| Normal-vs-N1 |
1.304970E-03 |
| Normal-vs-N2 |
2.682400E-01 |
| N0-vs-N1 |
1.694490E-02 |
| N0-vs-N2 |
9.257800E-01 |
| N1-vs-N2 |
3.112800E-01 |
|
|
